National Polytechnic Institute Mexico
Helmy M. Siragy
University of Virginia Health System USA
University of Florida USA
Juntendo University Japan
University of Colorado USA
Mount Sinai University USA
Sarah X. Zhang
State University of New York USA
Keio University Japan
Recommended Global Diabetes & Endocrinology Webinars & Conferences
Diabetes Meeting 2024
With the amalgamation of peerless speakers of Diabetes 2023 Conference Series is privileged to announce its “35th International Congress on Prevention of Diabetes and Complications” which will be held on May 23-24, 2024 in Zurich, Switzerland. We cordially welcome all the eminent researchers, students and delegates to take part in this upcoming Diabetes conference to witness invaluable scientific discussions and contribute to future innovations in the field of Diabetes.
According to WHO, about 60 million people with diabetes in the European Region. About 10.3% of men and 9.6% of women aged 25 years and over. Worldwide, high blood glucose kills about 3.4 million people annually amongst 80% of these deaths occur in low- and middle-income countries, and almost half are people aged under 70 years. WHO projects diabetes deaths will double between 2005 and 2030. The overall risk of death among people with diabetes is at least double the risk of their peers without diabetes. Reflecting this imperative, Conference Series is all set to host Diabetes webinar this year which will provide the future leadership in this key area for global health.
Diabetes Meeting 2024 will focus on the latest and exciting innovations in all areas of Diabetes research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. The two days conference includes workshops, symposiums, special keynote sessions conducted by eminent and renowned speakers who excel in the field of Diabetes which include: Advanced Technologies for Treatment of Diabetes, Emerging Focus in Diabetes Research, Diabetes Research in Clinical Practice, Computational Biology of Diabetes, Cell Therapy for Diabetes and its Complications, Genetics of Diabetes, Diabetes Management, Transplantation for Diabetes, Endocrinology Disorders and Treatment.
Young Research’s Awards at Diabetes Meeting 2024 for the Nomination: Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation, only 25 presentations acceptable at the Diabetes Meeting 2024 young research forum.
- Young Scientist Award recognition certificate and memento to the winners
- Our conferences provide best Platform for your research through oral presentations.
- Learn about career improvement with all the latest technologies by networking.
- Young Scientists will get appropriate and timely information by this Forum.
- Platform for collaboration among young researchers for better development.
- Provide an opportunity for research interaction and established senior investigators across the globe in the field
- Share the ideas with both eminent researchers and mentors.
It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge.
Diabetes Meeting 2024 provides best platform to expand your network, where you can meet scientists, authorities and CROs from around the world. It’s your time to grab the opportunity to join Diabetes conferences for promoting your research article and to facilitate prestigious award in all categories. In this fame, we look forward for your contribution and astonishing dedication to make our conference more successful.
Sessions & Tracks
Track 01: Complications associated with Diabetes
The term diabetes mellitus describes several diseases of abnormal carbohydrate metabolism that are characterized by hyperglycaemia. It is associated with a relative or absolute impairment in insulin secretion, along with varying degrees of peripheral resistance to the action of insulin. They are derived after doing many clinical trials on animal models. Every few years, the diabetes community revaluates the current recommendations for the classification, diagnosis, and screening of diabetes, reflecting new information from research and clinical practice which in turns help in understanding current prevention and treatment options and cost effectiveness in treatment and prevention of Diabetes. People with type1 and type2 diabetes have an increased risk of developing a number of serious health problems. Consistently high blood glucose levels can lead to serious diseases affecting the Macro vascular and micro vascular complications. In addition, people with diabetes also have a higher risk of developing infections. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease, blindness, kidney failure, and lower limb amputation. Maintaining blood glucose levels, blood pressure, and cholesterol at or close to normal can help delay or prevent diabetes complications. Hypoglycaemia and Hyperglycaemia are the other two factors are the two major complications of diabetes where hyperglycaemia is an acute complication sharing many symptoms and hypoglycaemia is an acute complication of several diabetes treatments. Glycosylated haemoglobin is a form of haemoglobin that is measured primarily to identify the average plasma glucose concentration over prolonged periods of time.
- Type 1 diabetes
- Type 2 diabetes
- Macro vascular complications
- Micro vascular complications
- Cardiovascular disease
Track 02: Genetics of Diabetes
Diabetes constitutes a major public health problem. Although substantial progress has been made in defining the genetics of metabolic syndrome risk for specific subtypes of diabetes (e.g., maturity-onset diabetes of the young), the majority of genetic risk of diabetes (for type 1 and type 2) remain unresolved. This review focuses on the current knowledge of the genetic basis of diabetes and its complications, specifically diabetic nephropathy (DN), recent advances in genetics of diabetes, diabetes in ethnic groups, genetic lifestyle interactions and understanding the genetics of Diabetes. Ultimately, identification of genes that contribute to risk (or protection) of diabetes and its complications will allow identification of patients who have diabetes and are at risk and targeted treatment/interventional strategies. Diabetic amyotrophic is a disabling illness that is distinct from other forms of diabetic neuropathy.
The concept of 'new technologies' for type 1 diabetes and new discovery and advanced type 2 diabetes treatment has expanded in recent years at a rate that some might consider comparable to 'Moore’s Law', and the sheer number of new technologies entering into the type 1 diabetes marketplace is also growing at a remarkable rate. From the patient’s perspective, this is not only exciting but can lead to a sense of optimism. Technologies that today are growing commonplace (e.g. insulin pumps, rapid HbA1c monitoring, etc come under new therapeutic mechanisms of diabetes. Indeed, it could be argued that the major advances in type 1 diabetes care made within the last quarter of a century have come from technology rather than biology. At the same time, not all new technologies succeed (e.g. the Glucowatch), regardless of their purported promise. Both type 1 diabetes patients and their healthcare providers will soon see a series of further advanced medical technologies used in hospital and new technologies and novel therapies in diabetes treatment whose basis is tied to the notion of improving the lives of those with the disease.
- Insulin pumps
- HbA1c monitoring
- Advanced medical technologies
Track 04: Diabetes Management
The main goal of diabetes management is, as far as possible, to restore carbohydrate metabolism to a normal state. To achieve this goal, individuals with an absolute deficiency of insulin require insulin replacement therapy, which is given through injections or an insulin pump. Insulin resistance, in contrast, can be corrected by dietary modifications and exercise. Other goals of diabetes management are to prevent or treat the many complications that can result from the disease itself and from its treatment. Healthy eating is a cornerstone of healthy living — with or without diabetes. But if you have diabetes, you need to know Impact of Food and Nutrition, impact of physical activity and yoga therapy in Diabetes Management. Diabetic foot complications result in huge costs for both society and the individual patients. Few reports on the health-economic consequences of diabetic foot infections have been published. Standards of medical care in Diabetes increased when compared to previous year.
- Carbohydrate metabolism
- Insulin replacement therapy
- Dietary modifications
- Yoga therapy
Track 05: Emerging Focus in Diabetes Research
Diabetes is a common chronic disease that imposes considerable demands on the individual healthcare system. People with diabetes have a higher rate of cardiovascular disease than those without diabetes and are at increased risk for kidney failure, lower limb amputation and blindness. Obesity is a significant risk factor for diabetes and the prevalence of obesity in children and adults has dramatically increased in the past four decades. Diabetic dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. The characteristic features of diabetic dyslipidemia are a high plasma triglyceride concentration, low HDL cholesterol concentration and increased concentration of small dense LDL-cholesterol particles. In order to investigate the bioinformatics tools and methodologies used to in diabetes research, at first, this was difficult to do because it did not have a preconceived idea about how the research would be organized and how bioinformatics tools would be described or identified in the research. To get started, we ran several cursory searches using basic search terms such as bioinformatics and diabetes (research) through several databases to see what types of articles were returned. Diabesity can be defined as a metabolic dysfunction that ranges from mild blood sugar imbalance to full-fledged type 2 diabetes. A bolus dose is insulin that is specifically taken at meal times to keep blood glucose levels under control following a meal.
- Diabetic dyslipidemia
- Metabolic dysfunction
- Blood sugar imbalance
Track 06: Transplantation of Diabetes
Getting a new heart, liver, kidney, lung, or other organ can save your life. Sometimes, it can also lead to type 2 diabetes. Many people can stop taking steroids after 6 months or so. This may solve the problem. If scientists can develop safe immunosuppressant’s that always work, then many people with type 1 diabetes may choose to have pancreas transplants. Until then, many doctors think islet transplants are a better option even after performing clinical trials on islet transplants. Islets are clusters of cells in the pancreas that make insulin. In people with type 1 diabetes, islet cells are destroyed. Only 1-2% of the pancreas is made up of islet cells. In pancreatic islet transplantation, cells are taken from a donor pancreas and transferred into another person. Once implanted, the new islets begin to make and release insulin. Researchers hope that islet transplantation will help people with type 1 diabetes live without daily injections of insulin. A transplant of the pancreas is usually reserved for those with serious complications. Pancreas transplants are most often done when a patient also receives a new kidney. The pancreas transplant adds little further risk in this situation and offers big benefits. However, transplant surgery is risky. Each person needs to carefully weigh the potential benefits and risks. Xenotransplantation for the treatment of type 1 diabetes is the transplantation of living cells, tissues or organs from one species to another. Such cells, tissues or organs are called xenografts or xenotransplants. A bolus dose is insulin that is specifically taken at meal times to keep blood glucose levels under control following a meal. Bolus insulin needs to act quickly and so short acting insulin or rapid acting insulin will be used where as Conventional insulin therapy is a therapeutic regimen for treatment of diabetes mellitus which contrasts with the newer intensive insulin therapy.
- Type 1 diabetes
- Type 2 diabetes
- Islet transplants
Track 07: Diabetes Research in Clinical Practice
Novel therapeutic targets available for diabetes includes Incretin based therapies, oral therapeutic agents like secretagogues, beta cell regeneration & proliferation and stem cell therapies. Embryonic stem cell and fetal precursor cell transplantation therapies are the major stem cell therapies available for Diabetes. Apart from the above, various computational approaches in Diabetes management control have been introduced recently which are playing an important role in identification of genes causing diabetes helping in Early Detection of Diabetes. These processes are also useful in studying the chemical etiologies of Diabetes uncovering various treatment prospects and model construction processes for survival prediction.
- Beta cell regeneration
- Stem cell therapies
Track 08: Computational Biology of Diabetes
Computational meta-analysis can link environmental chemicals to genes and proteins involved in human diseases, thereby elucidating possible aetiologies. The recent rapid development of a variety of analytical platforms based on mass spectrometry and nuclear magnetic resonance have enabled identification of complex metabolic Syndrome phenotypes. Continued development of bioinformatics and analytical strategies has facilitated the discovery of causal links in understanding the pathophysiology of diabetes and its complications.
- Syndrome phenotypes
Diabetes is always accompanied by a number of serious health issues. Consistent increase in blood glucose levels can lead to serious diseases affecting the vital organs of body like heart and blood vessels, eyes, kidneys, nerves and teeth. In almost all high-income countries, diabetes is a leading cause of cardiovascular disease like diabetic cardiomyopathy being one of the major risk factor, blindness, kidney failure, and lower limb amputation. Diabetic Retinopathy causes progressive damage to the retina in the patients with diabetes adding as the most vulnerable risk for the patient. Maintaining blood glucose levels, blood pressure, diabetic gastro paresis which has been reported to have the main cause as Diabetes Mellitus and cholesterol at or close to normal can help delay or prevent diabetes complications.
- Blood glucose levels
- Cardiovascular disease
- Diabetic cardiomyopathy
- Kidney failure
- Diabetic Retinopathy
- Diabetes Mellitus
Track 10: Endocrinology: Disorders and Treatment
Endocrinology is the study of hormones and the treatment of hormone based diseases. The endocrine glands produce chemicals called hormones. These hormones are released into the blood stream and exert their action by stimulating other organs in the body. However, Clinical trials on endocrinology look at new ways to prevent, detect, or treat disease. The major endocrine glands are the thyroid, pancreas, parathyroid, adrenal, gonad and pituitary. The hormones from these glands regulate growth, metabolism, blood pressure, reproduction as well as many other necessary functions. Early Diagnosis and Treatment of Endocrine Disorders, written by a distinguished panel of clinical experts and research scientists, focuses on the early signs and symptoms of common endocrine diseases, surveys the clinical testing needed for a diagnosis, and concisely presents the best current recommendations for therapy. Paediatric endocrinology is a medical subspecialty that studies and treats conditions affecting physical growth and sexual development in children, as well as diabetes and other disorders of the endocrine (hormone) glands.
- Endocrine Disorders
- Paediatric endocrinology
- Early Diagnosis and Treatment
- Endocrine (hormone) glands
Track 11: Diabetes Mellitus Type 1
Diabetes mellitus type 1 (otherwise called type 1 diabetes) is a type of diabetes mellitus that outcomes from the immune system annihilation of the insulin-delivering beta cells in the pancreas. The ensuing absence of hypoglycaemic agent prompts expanded aldohexose within the blood and pee. The established manifestations are regular pee, expanded thirst, expanded yearning, and weight reduction. The reason for diabetes type one is obscure. Type 1 diabetes is recognized from kind two from antibody testing. The C-peptide test, which measures endogenous insulin generation, can likewise be utilized. Organization of insulin is fundamental for survival. Insulin treatment must be proceeded with uncertainly and commonly does not disable ordinary every day exercises. Individuals are usually ready to freely take care of their diabetes; be that because it could, for a few these will challenge. Untreated, diabetes can bring about numerous confusions. Intense confusions incorporate diabetic ketoacidosis and non-ketotic hyperosmolar trance like state. Genuine end of the day complexities known with high glucose incorporate coronary unwellness, stroke, kidney disappointment, foot ulcers and harm to the eyes. Moreover, confusions could emerge from low aldohexose caused by extortionate hypoglycemic agent treatment. Diabetes mellitus type 1 represents around five-hitter and 100% of all diabetes cases.
Track 12: Diabetes Mellitus Type 2
Type 2 diabetes may be a long-term metabolic turmoil that's pictured by high aldohexose, insulin resistance, and relative absence of insulin. Basic aspect effects incorporate expanded thirst, incessant pee, and unexplained weight reduction. Indications could likewise incorporate swollen desire, feeling tired, and bruises that don't recuperate. Regularly indications go ahead gradually. Long haul complexities from high aldohexose incorporate coronary malady, strokes, diabetic retinopathy which can bring about visual impairment, kidney disappointment, and poor blood stream in the appendages which may prompt removals. The sudden onset of hyperosmolar hyperglycaemic state may happen; in any case, diabetic ketoacidosis is unprecedented. Type 2 diabetes is mostly preventable by staying a typical weight, practicing consistently, and eating legitimately. Treatment includes activity and dietary changes. In the event that aldohexose levels aren't sufficiently brought down, the medicine metformin is regularly suggested. Numerous individuals may in the end likewise require insulin infusions. In that on insulin, routinely check glucose levels is exhorted, in any case this may not be required in those taking pills. Bariatric surgery of times enhances diabetes within the people UN agency ar stout. Diabetes mellitus may be a devastating and sophisticated metabolic malady, expected to affect over 500 million people worldwide by the year 2030; up from 350 million in 2010. Approximately 95% of patients suffer from type 2 diabetes, and its prevalence is expected to increase in the future.
Track 13: Diabetes Research
Diabetes may be a common chronic illness that imposes right smart demands on the individual tending system. Individuals with polygenic disease have the next rate of disorder than those while not diabetes and are at multiplied risk for renal disorder, lower limb amputation and vision defect. Fleshiness may be an important risk issue for diabetes and also the prevalence of fleshiness in youngsters and adults has dramatically multiplied within the past four decades. Diabetic dyslipidemia is one among the foremost risk factors for disorder in diabetes. The characteristic options of diabetic dyslipidemia are a high plasma lipid concentration, low cholesterol concentration and multiplied concentration of tiny dense LDL-cholesterol particles. So as analysis to analyze the bioinformatics tools and methodologies accustomed in polygenic disease research, at first, this was tough to try and do as a result of it failed to have a preconceived notion concerning however the analysis would be organized and the way bioinformatics tools would be delineated or known within the analysis. To urge started, we tend to ran many perfunctory searches exploitation basic search terms like bioinformatics and diabetes (research) through many databases to examine what varieties of articles were came. Incapacity is outlined as a metabolic dysfunction that ranges from delicate glucose imbalance to full-fledged kind a type 2 diabetes. A bolus dose is internal secretion that's specifically taken at meal times to stay glucose levels in check following a meal.
Track 14: Diabetes Ophthalmology
Diabetic retinopathy is that the most typical diabetic disease and a number one explanation for visual impairment in adults within the U.S. It is caused by changes within the blood vessels of the membrane. The membrane is that the sensitive tissue at the rear of the attention. A healthy retina is necessary for good vision. Diabetic retinopathy is detected throughout an expanded eye communicating by associate degree specialist or specialist. A communicating by your primary doctor, during whom your eyes are not dilated, is not an adequate substitute for a full exam done by an ophthalmologist. Eye exams for individuals with polygenic disorder will include: sight testing. Diabetic retinopathy affects blood vessels within the sensitive tissue known as the membrane that lines the rear of the attention. It is the foremost common explanation for vision loss among individuals with polygenic disorder and therefore the leading explanation for vision impairment and visual impairment among working-age adults.
Diabetes can harm your eyes. It will harm the little blood vessels in your membrane, or the back of your eye. This condition is called diabetic retinopathy. Diabetes conjointly will increase your risk of eye disease and alternative eye issues. There is no cure for diabetic retinopathy. But optical device treatment surgical procedure is typically terribly effective at preventing vision loss if it's done before the membrane has been severely broken. Surgical removal of the vitreous gel (vitrectomy) may additionally facilitate improve vision if the membrane has not been severely broken. Diabetic Retinopathy Market was valued at $966 million in 2015, and is expected to reach $2,490 million by 2022, supported by a CAGR of 14.4% during the forecast period 2014 to 2022.
“35th International Congress on Prevention of Diabetes and Complications which is going to be held on May 23-24, 2024 in Zurich, Switzerland.
Past Conference Report
Diabetes Meeting 2023
We had a huge success with the completion of 34th International Congress on Prevention of Diabetes and Complications which was held in October 02-03, 2023 as London, UK. The significance of the meeting was achieved due to the accumulation of all the related group of spectators of research scientists to share their Knowledge, Research work, Technologies, and furthermore trade of worldwide Information towards the correct crowd at ideal time. Congress has received a generous response from all over the world. This has been organized with the aim of endorsing the development of new perceptions and ideas for investigating the high level of knowledge reached by scientific community in the field of Diabetes.
The conference was organized around the theme “Explore the Latest Trends and Advances in Diabetes Management”. The congress entrenched a firm relation of future strategies in the field of Diabetes.
Bookmark your dates for “Diabetes Meeting 2024,” as the Nominations for Best Poster Awards and Young Researcher Awards are open across the world.
Past Reports Gallery